期刊： CLINICAL AND EXPERIMENTAL ALLERGY, 2022; 52 (1)
Background Dietary antioxidants may protect the lung against oxidative damage and prevent chronic respiratory disease. We aimed to investigate fruit, ......
期刊： CLINICAL AND EXPERIMENTAL ALLERGY, 2022; 52 (12)
Background Allergen immunotherapy (AIT) represents the only possibility of causal therapy for allergic respiratory diseases. Although the prevailing h......
期刊： CLINICAL AND EXPERIMENTAL ALLERGY, 2022; 52 (10)
Background In previous studies with peripheral blood cells, platelet factors were found to be associated with severe allergic phenotypes. A reliable m......
期刊： CLINICAL AND EXPERIMENTAL ALLERGY, 2022; 52 (10)
Background Only a small number of apps addressing allergic rhinitis (AR) patients have been evaluated. This makes their selection difficult. We aimed ......
期刊： CLINICAL AND EXPERIMENTAL ALLERGY, 2022; 52 (5)
Background Severe asthma is a major cause of morbidity. Some patients may benefit from biological therapies. Most evaluations of these treatments are ......
